In one RCT, Breedveld et al. (2006) demonstrated that combination therapy with adalimumab and methotrexate (MTX) significantly improved RA symptoms and clinical remission, with adverse event profiles comparable to MTX alone, but observed no cases of lymphoma in the anti-TNF-α group and only one case in the conventional therapy group [17]. The gene discussed is TNF; the disease is lymphoma.